Earkart Limited (EARKART) — shareholding pattern, promoter holding, financials and share price
About Earkart Limited (EARKART)
Earkart Limited operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as EARKART and on the BSE under scrip code 544549. Its ISIN is INE1A8F01035.
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions
Earkart Limited focuses on manufacturing and distributing affordable hearing aids and accessories, emphasizing innovation and technology integration.
The company has developed the Earkart OMNI, a remote audiometry device that facilitates hearing tests across remote locations, drastically improving accessibility to audiological services.
Listed peers in Medical Equipment & Supplies: Yash Optics & Lens Ltd, Aprameya Engineering Ltd, Nureca Ltd, QMS Medical Allied Services Ltd, Avience Biomedicals Ltd, Choksi Asia Ltd.
Valuation & Returns
At ₹160 a share, Earkart Limited (EARKART) was valued at a price-to-earnings ratio of 44.6x against an industry P/E of 44.11x and a price-to-book of 3.4x on a book value of ₹47.02 per share. Solomo computes return on equity of 7.67% and return on capital employed of 12.12% from filed results.
- P/E
- 44.6x
- Industry P/E
- 44.11x
- P/B
- 3.4x
- Book value / share
- ₹47.02
- ROE
- 7.67%
- ROCE
- 12.12%
- ROA
- 7.09%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 15.66%
- 52-week range
- ₹104.35 – ₹265.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Earkart Limited (EARKART) reported revenue of ₹54.04 crore, net profit of ₹4.93 crore and earnings per share of ₹3.58. That compares with revenue of ₹43.11 crore and net profit of ₹6.88 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹31.75 crore and net profit ₹3.08 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 5.66 | 28.92 | 31.75 | 43.11 | 54.04 |
| Net profit (₹ cr) | 0.11 | 1.31 | 3.06 | 6.88 | 4.93 |
| EPS (₹) | 22 | 262 | 612 | 6.59 | 3.58 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 96.38% | 35.78% |
| Profit growth | 302.42% | 124.84% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 57.34% of Earkart Limited (EARKART) and domestic institutional investors (DII) hold 21.95%. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2026.
Largest disclosed public shareholders in Mar 2026: NEOMILE GROWTH FUND- SERIES -I 16.92%, ASHNEER GROVER 4.45%, BLUME VENTURES INDIA FUND 3.04%, SAUMIK KETANKUMAR DOSHI 2.91%, KRITI BEARINGS PRIVATE LIMITED 1.61%, SUSHMA NINAD SHAH 1.41%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 57.34% | - | - | 21.95% | 42.66% |